Cargando…
Immunosuppression medication and cardiac function improvement treatments might prevent Takayasu arteritis patients with aortitis from receiving cardiac surgery
Autores principales: | Dai, Xiao-Min, Wang, Yu-Jiao, Zhang, Zhen-Chun, Yang, Cheng-De, Wu, Rui, Zhou, Zhen-Yuan, Chen, Xiao-Xiang, Sun, Xiao-Ning, Wang, Chun-Sheng, Ma, Li-Li, Jiang, Lin-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929491/ https://www.ncbi.nlm.nih.gov/pubmed/33060369 http://dx.doi.org/10.1097/CM9.0000000000001160 |
Ejemplares similares
-
Concurrence of Sarcoidosis and Takayasu Aortitis
por: Liu, Yuan, et al.
Publicado: (2015) -
Familial HLA-B*52 Vasculitis: Maternal, Atypical Cogan's Syndrome with Takayasu Arteritis-mimicking Aortitis and Filial Takayasu Arteritis
por: Morinaka, Satoshi, et al.
Publicado: (2020) -
Catastrophic Cardiac Complications of Takayasu’s Arteritis
por: Godil, Sara A, et al.
Publicado: (2020) -
Takayasu Arteritis Causing Aortitis and Aortic Regurgitation: A Totally Tubular Case Report
por: Boparai, Navdeep, et al.
Publicado: (2020) -
Might IgA be a Biomarker of Disease Activity in Takayasu Arteritis?
por: Vantaggio, Lorenzo, et al.
Publicado: (2022)